Skip to main content
Livermore
Livermore
ZHEN

NovoCure Ltd

NVCR
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001645113

No open-market purchases or sales by NovoCure Ltd insiders were filed in the last 90 days; 218 institutions reported holding it in 13F filings for Q2 2026, worth $1.57B in total; no superinvestor holds it.

Holders of 5% or more of NVCR

Holders whose latest Schedule 13D or 13G filing reports 5% or more of NovoCure Ltd, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of NVCR
HolderLatest formStakeChangeFirst filedLatest filingFiling
Soleus Capital Master Fund, L.P.13G/A9.10%10.5M shares+1.50 ppfrom 7.60%Apr 1, 20255 filingsMay 8, 2026SEC
BlackRock, Inc.13G/A8.30%9.08M shares–Apr 23, 20251 filingApr 23, 2025SEC
Vanguard Portfolio Management LLC13G5.57%6.34M sharesNewApr 28, 20261 filingApr 28, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

25 Schedule 13D and 13G filings on NovoCure Ltd, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on NVCR
Filed (ET)FilerFormStakeChangeEvent dateFiling
May 8, 20265:01 PM ETSoleus Capital Master Fund, L.P.and 5 others13G/A9.10%10.5M shares+1.50 ppfrom 7.60%Mar 31, 2026SEC
Apr 28, 20263:29 PM ETVanguard Portfolio Management LLC13G5.57%6.34M sharesNewMar 31, 2026SEC
Mar 26, 202611:52 AM ETVanguard Group Inc13G/A0.00%0 shares–Below 5%Mar 13, 2026SEC
Feb 12, 20265:01 PM ETSoleus Capital Master Fund, L.P.and 5 others13G/A7.60%8.53M shares−1.00 ppfrom 8.60%Dec 31, 2025SEC
Nov 13, 20257:06 PM ETCapital World Investors13G/A1.80%2.00M shares−3.90 ppfrom 5.70%Below 5%Sep 30, 2025SEC
Nov 7, 20254:00 PM ETSoleus Capital Master Fund, L.P.and 5 others13G/A8.60%9.64M shares+2.40 ppfrom 6.20%Sep 30, 2025SEC
Aug 13, 202512:56 PM ETCapital World Investors13G5.70%6.38M shares–Jun 30, 2025SEC
Aug 5, 20255:00 PM ETSoleus Capital Master Fund, L.P.and 5 others13G/A6.20%6.90M shares+1.20 ppfrom 5.00%Jun 30, 2025SEC
Jul 7, 20251:42 PM ETCapital International Investors13G/A0.00%0 shares–Below 5%Jun 30, 2025SEC
Apr 23, 20258:00 PM ETBlackRock, Inc.13G/A8.30%9.08M shares–Mar 31, 2025SEC
Apr 1, 20255:00 PM ETSoleus Capital Master Fund, L.P.and 5 others13G5.00%5.52M sharesNewMar 31, 2025SEC
Feb 13, 2023Capital International Investors13G/AOld format–––SEC
Feb 13, 2023Capital World Investors13G/AOld format–––SEC
Feb 9, 2023Vanguard Group Inc13G/AOld format–––SEC
Feb 9, 2023FMR LLC13G/AOld format–––SEC
Jan 23, 2023Baillie Gifford & Co13G/AOld format–––SEC
Apr 11, 2022FMR LLC13G/AOld format–––SEC
Feb 11, 2022Capital International Investors13G/AOld format–––SEC
Feb 11, 2022Capital World Investors13G/AOld format–––SEC
Feb 10, 2022Vanguard Group Inc13G/AOld format–––SEC
Feb 9, 2022FMR LLC13G/AOld format–––SEC
Feb 3, 20224:41 PM ETBlackRock Inc.13G/AOld format–––SEC
Jan 26, 2022Baillie Gifford & Co13G/AOld format–––SEC
Aug 10, 2021Capital International Investors13G/AOld format–––SEC
May 10, 2021Capital World Investors13G/AOld format–––SEC
Feb 16, 2021Capital International Investors13GOld format–New–SEC
Feb 16, 2021Capital World Investors13G/AOld format–––SEC
Feb 10, 2021Vanguard Group Inc13G/AOld format–––SEC
Feb 8, 2021FMR LLC13G/AOld format–––SEC
Feb 5, 20218:03 AM ETBlackRock Inc.13GOld format–New–SEC
Feb 1, 2021Wyss Hansjoerg13G/AOld format–––SEC
Jan 14, 2021Baillie Gifford & Co13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell NovoCure Ltd shares.

No Form 144 notices for NovoCure Ltd are on file.